Stepan (NYSE:SCL – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Wednesday, July 26th. Analysts expect the company to announce earnings of $1.25 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Stepan (NYSE:SCL – Get Free Report) last announced its quarterly earnings results on Tuesday, April 25th. The basic materials company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.23). Stepan had a net margin of 4.31% and a return on equity of 11.20%. The firm had revenue of $651.40 million during the quarter, compared to the consensus estimate of $649.73 million. During the same quarter in the previous year, the company posted $1.76 earnings per share. The firm’s revenue was down 3.5% on a year-over-year basis. On average, analysts expect Stepan to post $4 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Stepan Stock Up 3.4 %
Shares of SCL opened at $96.18 on Wednesday. Stepan has a 52 week low of $87.11 and a 52 week high of $116.72. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of 18.71 and a beta of 0.83. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.96 and a current ratio of 1.52. The stock has a fifty day moving average of $93.72 and a 200-day moving average of $99.61.
Stepan Announces Dividend
Analysts Set New Price Targets
Several research analysts recently issued reports on the company. TheStreet lowered Stepan from a “b-” rating to a “c” rating in a research report on Wednesday, May 17th. StockNews.com lowered Stepan from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th.
Insider Buying and Selling
In other Stepan news, CEO Scott R. Behrens sold 2,000 shares of the stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $89.91, for a total transaction of $179,820.00. Following the completion of the sale, the chief executive officer now directly owns 12,756 shares in the company, valued at approximately $1,146,891.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Stepan news, VP Arthur W. Mergner sold 1,996 shares of the stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $98.23, for a total transaction of $196,067.08. Following the completion of the sale, the vice president now directly owns 27,516 shares in the company, valued at approximately $2,702,896.68. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Scott R. Behrens sold 2,000 shares of the stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $89.91, for a total value of $179,820.00. Following the sale, the chief executive officer now owns 12,756 shares of the company’s stock, valued at $1,146,891.96. The disclosure for this sale can be found here. Insiders sold a total of 7,983 shares of company stock valued at $748,034 in the last three months. Insiders own 6.90% of the company’s stock.
Institutional Trading of Stepan
Large investors have recently made changes to their positions in the company. Two Sigma Investments LP acquired a new stake in shares of Stepan in the 4th quarter valued at about $424,000. CI Private Wealth LLC acquired a new stake in shares of Stepan in the 4th quarter valued at about $385,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Stepan in the 1st quarter valued at about $344,000. Raymond James & Associates grew its stake in shares of Stepan by 8.9% in the 1st quarter. Raymond James & Associates now owns 3,291 shares of the basic materials company’s stock valued at $325,000 after buying an additional 268 shares during the period. Finally, IHT Wealth Management LLC acquired a new stake in shares of Stepan in the 4th quarter valued at about $324,000. 76.63% of the stock is currently owned by institutional investors and hedge funds.
Stepan Company Profile
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used as principal ingredients in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients.
Read More
- Five stocks we like better than Stepan
- Green Hydrogen Stocks Getting Ready to Deliver Big Gains
- Charles Schwab Gets The Rebound, Time to Buy?
- Is Ebix Inc a Phygital E-Commerce Contender or Pretender?
- 3 Mid-Cap Stocks with Expectations for High-Earnings Growth
- Can Lockheed Martin Fly To A New High In 2023?
Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.
